BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32761083)

  • 1. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
    Pettit AC; Stout JE; Belknap R; Benson CA; Séraphin MN; Lauzardo M; Horne DJ; Garfein RS; Maruri F; Ho CS;
    Clin Infect Dis; 2021 Oct; 73(7):e2278-e2284. PubMed ID: 32761083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States.
    Zavala S; Winglee K; Ho CS; Pettit AC; Ahmed A; Katz DJ; Belknap RW; Stout JE
    Ann Am Thorac Soc; 2023 Sep; 20(9):1258-1266. PubMed ID: 37159954
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting.
    Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
    Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31416206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease.
    Ayers T; Hill AN; Raykin J; Mohanty S; Belknap RW; Brostrom R; Khurana R; Lauzardo M; Miller TL; Narita M; Pettit AC; Pyan A; Salcedo KL; Polony A; Flood J;
    JAMA Netw Open; 2024 Apr; 7(4):e244769. PubMed ID: 38568690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays.
    Talati NJ; Gonzalez-Diaz E; Mutemba C; Wendt J; Kilembe W; Mwananyanda L; Chomba E; Allen S; del Rio C; Blumberg HM
    BMC Infect Dis; 2011 Sep; 11():264. PubMed ID: 21962029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.
    Kaplan SR; Escudero JN; Mecha J; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart GC; LaCourse SM
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):98-107. PubMed ID: 34629414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of discordant latent tuberculosis infection test results amongst South African health care workers.
    Adams S; Ehrlich R; Baatjies R; Dendukuri N; Wang Z; Dheda K
    BMC Infect Dis; 2019 Feb; 19(1):131. PubMed ID: 30736743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.
    Talati NJ; Seybold U; Humphrey B; Aina A; Tapia J; Weinfurter P; Albalak R; Blumberg HM
    BMC Infect Dis; 2009 Feb; 9():15. PubMed ID: 19208218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
    Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
    BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive rate and risk factors of latent tuberculosis infection among persons living with HIV in Jiangsu Province, China.
    Zhang Y; Lu P; Wu K; Zhou H; Yu H; Yuan J; Dong L; Liu Q; Lu W; Yang H; Cao D; Zhu L
    Front Cell Infect Microbiol; 2023; 13():1051060. PubMed ID: 36960041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
    Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
    BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.